Clinical Trial Update: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation [Phase 2]

View source ↗

Summary

A multicenter, double-blind, randomized, placebo-controlled Phase 2 dose-range-finding trial of YKP10811 for chronic idiopathic constipation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation

Drugs mentioned

• YKP10811

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Chronic Idiopathic Constipation | Phase 2 | Status: COMPLETED